Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, millions of individuals worldwide have been infected by the virus

While the available coronavirus disease 2019 (COVID-19) vaccines have demonstrated good efficacy in reducing transmission of severe acute respiratory syndrome

Severe acute respiratory coronavirus 2 (SARS-CoV-2) has affected millions with coronavirus disease 2019 (COVID-19). Despite vaccines being available to prevent

Coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. With few treatments, a rapid transmission rate, and

Since it was first detected in Wuhan, China, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly across

A team of researchers has demonstrated that the impact of the coronavirus disease 2019 (COVID-19) pandemic on excess mortality varied

In early August 2021, a research group reported the effectiveness of vaccination against the transmission of SARS-CoV-2 in the Netherlands

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown low transmission rates on flights and more so in domestic flights

In a review published in Vaccines, two researchers from the University of Illinois and Mercer University have collaborated to review

In a new study published on the preprint server medRxiv*, researchers investigate a number of drugs that are believed to